You are still blind to the words "placebo controlled". There IS a placebo arm. The fact that both arms are given CS doesn't change that. There HAS to be a control arm.
Go back to that school of yours.
And you'd better hope MSB's BLA for remestemcel fails because if they get approval for treating aGvHD your trial will flop like MEND. I believe CYP-001 could get very good results in this trial but who'd risk getting placebo (yes, there is a placebo arm) when there is an FDA approved, high quality and financially supported treatment that is backed by the leading clinician? All your boringly repetitive drivel about manufacturing is irrelevant there.
CYP Price at posting:
31.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)